All our services include access to fully automated, remote-controlled
protein-to-structure pipelines based on the innovative technologies
CrystalDirect™ and CRIMS developed at EMBL.
Establishing new crystal systems for challenging targets.
Establishing new crystal systems for challenging targets.
Parallel screening of compounds to support MedChem and structure-based drug design.
Parallel screening of compounds to support MedChem and structure-based drug design.
High-throughput, state-of-the-art fragment screening, covering a highly diverse chemical space – libraries provided by the client or ALPX.
High-throughput, state-of-the-art fragment screening, covering a highly diverse chemical space – libraries provided by the client or ALPX.
X-ray data collection of crystals at multiple synchrotrons and structure solution of biomolecules, including ligand and binding site refinement.
X-ray data collection of crystals at multiple synchrotrons and structure solution of biomolecules, including ligand and binding site refinement.
A fully automated technology for processing and harvesting of crystals, based on laser-induced photoablation.
An interactive online software suite that tracks experiments and results, and makes them available to scientists in real-time through intuitive interfaces.
ALPX is an EMBL spin-off, based at the European Photon Neutron campus in
Grenoble, France. It provides structural biology services and expertise
to pharmaceutical and biotech companies to accelerate
the drug discovery process.
ALPX
71 avenue des Martyrs
38000 Grenoble – France